|
Volumn 75, Issue 7, 1995, Pages 1642-1648
|
Enhanced reverse transcriptase‐polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer
a a a a a a a a a |
Author keywords
prostate cancer; PSA; RT PCR; staging
|
Indexed keywords
FLUTAMIDE;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
ARTICLE;
CANCER HORMONE THERAPY;
CANCER INVASION;
CANCER RECURRENCE;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
PROSTATECTOMY;
RECURRENCE RISK;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ANDROGEN ANTAGONISTS;
HUMANS;
MALE;
NEOPLASM STAGING;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
|
EID: 0028906648
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19950401)75:7<1642::AID-CNCR2820750714>3.0.CO;2-1 Document Type: Article |
Times cited : (99)
|
References (24)
|